With antidotes now available for Pradaxa, Eliquis and Xarelto why are patients continuing to die from uncontrollable bleeding while on blood thinners? The answer unfortunately is that the antidote is expensive and hospitals are worried that they won’t get reimbursed for the cost of saving lives! Millions of Americans are on blood thinners (anticoagulants)…
There is promising news for the more than 4 million patients who take Xarelto® (Riviaroxaban) or Eliquis® (Aixaban) on a daily basis. These blood thinners, while effective, have been shown to cause uncontrolled and sometimes life-threatening bleeding events. The FDA has finally approved a reversal agent that can stop the anticoagulant effects of Xa inhibitors, in the form…
The latest update about the Xarelto litigation process is finally here. Plaintiffs from around the nation claim that Bayer’s anticoagulant medication Xarelto was defectively designed and marketed with inadequate warnings about the risk of uncontrolled bleeding. Approved by the FDA in 2011, Xarelto is prescribed to treat blood clots, deep vein thrombosis and pulmonary embolism,…